NASDAQ: SNESSenestech Inc Stock
$1.75-0.04 (-2.23%)
Updated Mar 25, 2026
SNES Price
$1.75
Fair Value Price
N/A
Market Cap
$9.28M
52 Week Low
$1.30
52 Week High
$6.24
P/E
-0.9x
P/B
0.97x
P/S
3.16x
PEG
N/A
Dividend Yield
N/A
Revenue
$2.22M
Earnings
-$6.38M
Gross Margin
62.5%
Operating Margin
-286.4%
Profit Margin
-287.4%
Debt to Equity
0.34
Operating Cash Flow
-$6M
Beta
0.84
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
SNES Overview
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine SNES's potential to beat the market
- SNES doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Specialty Chemical
Industry Rating
B
SNES
RankedUnranked of 50
RankedUnranked of 50
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $8.76 | A | |
| $4.38 | A | |
| $12.99 | A |
Be the first to know about important SNES news, forecast changes, insider trades & much more!
SNES News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SNES scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SNES is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SNES is good value based on its book value relative to its share price (0.97x), compared to the US Specialty Chemicals industry average (3.68x)
P/B vs Industry Valuation
SNES is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more SNES due diligence checks available for Premium users.
Valuation
SNES price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.9x
Industry
-1.88x
Market
31.81x
SNES price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.97x
Industry
3.68x
SNES is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SNES's financial health
Profit margin
Revenue
$421.0k
Net Income
-$1.8M
Profit Margin
-428.5%
SNES's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
SNES's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$12.8M
Liabilities
$3.3M
Debt to equity
0.34
SNES's short-term assets ($10.06M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SNES's short-term assets ($10.06M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SNES's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SNES's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.7M
Investing
$2.0M
Financing
-$26.0k
SNES's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
SNES vs Specialty Chemical Stocks
Senestech Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.